Abstract:
OBJECTIVE To study the clinical efficacy of Yishen Huayu Zhuyun Formula on polycystic ovary syndrome of kidney deficiency and blood stasis type and its effect on serum inflammatory factors and sex hormone levels in patients.
METHODS Patients with polycystic ovary syndrome of kidney deficiency and blood stasis type who visited Xinyu Hospital of Traditional Chinese Medicine (TCM) from May 2022 to July 2023 were included and randomly divided into a control group and an observation group, with 78 patients in each group. The control group received routine Western medicine treatment, while the observation group received Yishen Huayu Zhuyun Formula in addition to the treatment given to the control group. Both groups were treated for 3 menstrual cycles. The improvement of the total TCM syndrome score, uterine spiral artery resistance index (RI), and endometrial thickness on the day of ovulation before and after treatment was compared between the two groups. Pregnancy rates after treatment were also compared between the two groups. Changes in serum dehydroepiandrosterone sulfate (DHEAS), transforming growth factor-β1 (TGF-β1), insulin resistance index (HOMA-IR), interleukin-6 (IL-6), sex hormone-binding globulin (SHBG), and serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estrogen (E2) levels before and after treatment were measured in both groups.
RESULTS After treatment, the total TCM syndrome score and RI decreased in both groups, and the endometrial thickness on the day of ovulation increased, with the observation group showing better results than the control group (P<0.05, P<0.01). Serum DHEAS, TGF-β1, HOMA-IR, and IL-6 decreased in both groups, while SHBG increased, with the observation group superior to the control group (P<0.05, P<0.01). Serum LH and FSH decreased in both groups, while E2 increased, with the observation group outperforming the control group (P<0.05, P<0.01). After treatment, the ovulation rate and pregnancy rate in the observation group were both higher than those in the control group (P<0.05).
CONCLUSION Yishen Huayu Zhuyun Formula can significantly alleviate the inflammatory state in patients with polycystic ovary syndrome of the kidney deficiency and blood stasis type, regulate sex hormone levels, and has significant clinical efficacy.